Study protocol for a randomized controlled clinical trial
Natalia Osorio Viarengo, MS, Marcela Leticia Leal Gonçalves, PhD, [...], and Sandra Kalil Bussadori, PhD
Background:
The objective of this study will be to evaluate the effect of intravascular irradiation of blood (ILIB) combined with myofunctional exercises for sleep bruxism in pediatrics.
Methods:
This study will be a randomized controlled clinical trial. A triage of individuals between 4 and 17 years old with a diagnosis of sleep bruxism will be carried out at the clinic of the Catholic University of Uruguay, and in a private office referred by different private care centers. The selected participants will be evaluated before and after treatment by means of questionnaires on bruxism, sleep quality and nocturnal oxygen saturation measurement. For this, 46 patients with sleep bruxism will be recruited, who will be divided into 2 groups: control group (CG), which will undergo an application of placebo ILIB and an orofacial myofunctional therapy (MFT) exercise protocol; and na ILIB group, which will carry out an active application of ILIB and an exercise protocol, this being once a week for 8 weeks. The laser treatment (808 nm) will be performed twice a week for 8 weeks. The values will be tested for normality by the Kolmogorov–Smirnov test. For the comparison between the groups, t test will be carried out, considering a level of significance of 0.5% (P < .05).
Discussion:
Although local photobiomodulation (PBM), acupuncture PBM and physiotherapy have been studied in the treatment of bruxism, this is the first study to evaluate the effect of ILIB combined with myofunctional exercises for sleep bruxism in pediatrics.
Keywords: bruxism, intravascular irradiation of blood, myofunctional therapy, oximetry, photobiomodulation
1. Introduction
Bruxism is a repetitive activity that involves clenching or grinding the teeth during sleep or wakefulness.[1,2] In 2013, in an international consensus, it was defined as “a repetitive masticatory muscular activity, with clenching or grinding of the teeth and/or by the fixation (bracing) or thrust (thrusting) of the jaw.” In 2018, a new update was made, in which the thrust and fixation mandibular movements are defined in detail.[3] The grinding is generally audible and triggers discomfort or side effects for those who present it. This condition is commonly seen in children and adolescents.[4] If it is not identified and addressed in time, it can bring negative consequences such as tooth wear, periodontal disease, hypertrophy of the masticatory muscles, headache, limitation of mouth opening, muscle pain and temporomandibular disorders (TMD) and, in many cases, decrease in academic performance of the child or adolescent.[5]
Regarding the etiology of bruxism, there is consensus in the literature that bruxism has a multifactorial etiology.[6] The genetic causes related to a possible polymorphism, anxiety, some personality traits, and endocrine alterations associated with stress, among others, are considered. It has also been related to occlusal factors, malocclusion, nutritional deficiencies, respiratory problems (apneas, snoring), allergies, intestinal parasites, oral habits, changes in neurotransmitters such as dopamine and sleep quality.[7]
When it comes to the diagnosis of bruxism, there are controversies. Currently, it is considered that only polysomnography can give a definitive diagnosis, but this exam has a high cost.[8] Polysomnography allows simultaneous monitoring of electroencephalographic, electrocardiographic, electromyographic sleep, and respiratory signals during sleep.[9] Self-questionnaires are usually used (in the case of pediatrics it is completed by the parents or the referent), based on the criteria of the American Association of Sleep Medicine. The prevalence is highly controversial. In the analysis of systematic reviews, a prevalence of 22% to 31% for sleep bruxism in adults was shown.[10]
Regarding therapeutics, they are mostly palliative, addressing the symptom, but without providing a solution. A systematic review suggests that the evidence is still scarce in relation to drugs.[11] Botulinum toxin protects orofacial structures (teeth, jaw muscles, temporomandibular joint) reducing the damage caused by bruxism, generating a decrease in pain and symptoms related to excessive muscle contraction.[12] Occlusal devices, such as splints, are used to protect teeth from the damage caused by clenching and grinding during bruxism.[13] Photobiomodulation (PBM) is a very promising, painless and low-cost option; capable of stimulating or inhibiting cellular processes.[14] Intravascular Irradiation of Blood (ILIB), a systemic modality of PBM, can be used as a complementary therapy to other therapies.[15] It emits energy that activates neurohumoral regulation and synchronization and cell modulation with antioxidant, metabolic, immunological, antispasmodic, sedative, healing, analgesic, anti-inflammatory and blood circulation-increasing effects.[16,17] Orofacial myofunctional therapy (MFT) is a set of techniques and procedures whose objective is to promote changes in muscle patterns and orofacial functions through isotonic and isometric exercises with the orofacial and oropharyngeal muscles supported by the functions of breathing, chewing, swallowing and talk.[18] Orofacial MFT and systemic low intensity laser administration are options to more traditional therapies.
The objective of this study is to determine the efficacy of ILIB in sleep bruxism, in combination with oral MFT. It also aims to evaluate the relationship between oxygenation and bruxism during sleep and to determine the prevalence of nocturnal hypoxemia and its association with daytime oral breathing.
2. Methods/design
2.1. Study design
This is the first version of a study protocol for a randomized, controlled, parallel group, single blind, clinical trial, with a control group (CG) and na active comparator group, in which 46 individuals with a diagnosis of sleep bruxism will participate. The project was evaluated and approved by the Research Ethics Committee of Universidad Católica del Uruguay (process number 220211) and was registered in the Clinical Trials platform (https://clinicaltrials.gov/) with the number NCT05301452, first published on March 16, 2022 and last updated on August 4, 2022. Recruitment and treatments will be performed at the dentistry clinic of Universidad Católica del Uruguay clinics, during the period from September 1, 2022 to December 1, 2022.
This protocol is in accordance with the 2013 SPIRIT (Standard Protocol Items: Recommendations for Interventional Trials) Statement. The SPIRIT checklist can be found as an additional file and Figure Figure11 is the SPIRIT figure.
SPIRIT figure as recommended by 2013 SPIRIT statement. SPIRIT = standard protocol items: recommendations for interventional trials
2.2. Participants
A triage of individuals between 4 and 17 years old, diagnosed with sleep bruxism, will be carried out at the dentistry clinic of the Catholic University of Uruguay. Patients will already be in treatment for other conditions at the clinic, what will facilitate recruitment. It is believed that the need for treatment of bruxism before major pain symptoms or dental wear will help to improve adherence to the trial.
Inclusion criteria:
Children in the mixed dentition phase (permanent incisors and first molars erupted);
Or adolescents with an established permanent dentition.
Exclusion criteria:
People with dental caries;
Those taking medications, such as inflammatory agents, muscle relaxants, corticosteroids, anticonvulsants, and antidepressants;
Those with chronic diseases that affect muscles or motor coordination, and those who do not cooperate during the evaluation will be excluded from the study;
Children with cerebral palsy;
Patients whose guardians do not sign the informed consent or the participant who does not sign the assent form.
2.3. Experimental groups
Forty-six patients with sleep bruxism will be recruited and divided into 2 groups:
- CG which will undergo an application of placebo ILIB and an orofacial MFT exercise protocol;
- ILIB group, which will carry out an active application of ILIB and an orofacial MFT exercise protocol, this being once a week for 4 weeks.
2.4. Sample calculation
The sample was calculated to detect a significant difference between PBM and MFT with 80% power and a significance level of 5%, considering the oxygen saturation index. Based on the study by Aarab et al[19] to detect a difference in saturation index, with an effect size of 0.53, the minimum number per group should be 23 participants per group (Fig. (Fig.22).
Sample size calculation. Analysis: A priori: Compute required sample size; Input: Tail(s) = One; Effect size dz = 0.5373031; α err prob = 0.05; Power (1-β err prob) = 0.8; Output: Noncentrality parameter δ = 2.576815; Critical
2.5. Randomization
To randomly distribute the individuals in the experimental groups, a random sequence generator (https://www.randomizer.org/tutorial/) will be used. Opaque envelopes will be identified with each number and inside it a sheet containing the information of the corresponding experimental group will be inserted. The envelopes will be sealed and kept in a safe place until the time of the procedures. The generation of the sequence and the preparation of the envelopes will be performed by a person who is not involved in the study.
2.6. Blinding
The participants will not know whether they belong to the placebo/CG, or the active PBM group, seeing as the laser application will be simulated. Unblinding is not permissible.
2.7. Interventions
2.7.1. ILIB protocol.
The laser treatment will be performed by a speech therapist, using the wavelength of 660 nm. It will be done once a week for 4 weeks, in 20-minute sessions. In the CG, the ILIB procedure will be simulated, but with the laser turned off.
2.7.2. Orofacial MFT.
MFT will be performed by a speech therapist specialized in the area. It will consist of 1 weekly session, where the functions of breathing, chewing and swallowing will be evaluated and addressed.
The following exercises will be indicated: nasal hygiene, inflated cheeks with the tip of the tongue on the palate, lingual sweep, tongue thrust against the palate, tongue touch on the last molars, chewing of soft solids and bolus assembly (20 minutes therapy session).
3. Outcome measures
All participants will undergo a parent or referent bruxism questionnaire, infant sleep quality questionnaire, nocturnal oximetry, and clinical assessment of orofacial functions at baseline and after 4 weeks of treatment. Patient retention and complete follow-ups are expected due to the treatment of bruxism symptoms.
3.1. Oximetry
Recorded sleep oximetry monitoring has high specificity and sensitivity for the diagnosis of respiratory disorders in children. This is the primary outcome of the study.
A portable pulse oximeter that includes Masimo SET® Measure-through Motion and Low Perfusion™ pulse oximetry under motion and low perfusion conditions. Nocturnal oximetry will be performed prior to treatment and post treatment. The parents or guardian of the minor will be trained.
3.2. Breathing
A clinical evaluation will be carried out by a speech therapist specialized in the area of Orofacial Motricity, to check for possible improvement in breathing. It is the respiratory characterization from the taking of air, which explains the anatomical and topographical situation of its entrance to the respiratory system (respiratory mode), to the thoracoabdominal movement zone that integrates inspiration and expiration. It is supported by the observation with the aid of a Glatzel’s mirror to anatomically determine the upper airway status and its functional correlation.
3.3. Swallowing
A clinical evaluation will be carried out by a speech therapist specialized in the area of Orofacial Motricity, to check for possible improvement in swallowing. For this, the Payne’s test, which assesses tongue posture both at rest and in function (swallowing), will be used. From instruments such as liquid fluorescein applied to the apex lingual and lateral borders, and Payne’s lamp that verifies the vestige of the fluorescein, and therefore the conditions of support, thrust, position and/or obstruction of the tongue.
3.4. Chewing
A clinical evaluation will be carried out by a speech therapist specialized in the area of Orofacial Motricity, to check for possible improvement in chewing. For this, the gnathodynamometer, test that allows to measure the force of the occlusion, will be used.
3.5. Speech
A clinical evaluation will be carried out by a speech therapist specialized in the area of Orofacial Motricity, to check for possible improvement in speech. For this, the Glatzel test will be used to measure the degree of nasal patency and the functional symmetry of the upper airways both at rest and in function. Specifically in the functional evaluation, its usefulness is linked to the verification of the existence of nasality or hyponasality before vowels elicited by the patient.
3.6. Presence of bruxism
The bruxism questionnaire will be delivered to parents or guardians, which will be completed prior to treatment and afterwards. The questionnaire contains 4 questions regarding the perceived presence of bruxism, and 5 questions for the dentist to answer, based on a clinical observation. All questions have the options “yes” or “no.” The more times the word “yes” is chosen, the greater the risk for bruxism is.
3.7. Sleep quality
A Pediatric Sleep Quality Questionnaire will be delivered to parents or guardians, and it will be completed prior to treatment and afterwards. The questionnaire contains 44 questions regarding sleep quality. All questions have the options “yes” or “no.” The more times the word “yes” is chosen, the worse is the sleep quality.
3.8. Statistical analysis
The data will be tabulated and processed with the software GraphPad PRISM version 7.0. The values will be tested for normality by the Kolmogorov–Smirnov test, and will be expressed as mean and standard deviation if Gauss curve is assumed. For the comparison between the groups, the t test will be carried out, considering a level of significance of 0.5% (P < .05). No loses greater than 5% of the sample are expected.
4. Discussion
The treatment of bruxism is a challenge faced in the clinical practice. Treatment methods that are commonly used for treating bruxism in pediatric patients are kinesiotherapy, massage, infrared therapy, and PBM. Among them, PBM is noninvasive, cost-effective and painless.[20,21] A randomized controlled trial tested the effectiveness of PBM in acupuncture points as an alternative treatment for sleep bruxism. The researchers came to the conclusion that children with sleep bruxism responded well to PBM therapy, as evidenced by the reduction in bite force and reports of headache.[22]
A systematic review conducted in 2021 aimed to evaluate the efficacy of PBM in the treatment of myofascial pain associated with TMD, and to perform a cost-effectiveness analysis of TMD treatment with PBM in patients with myofascial pain. The authors came to the conclusion that laser-treated groups had painful symptoms improvement that was superior to the CG and PBM was more cost-effective than placebo in patients with TMD and myofascial pain.[23]
Physiotherapy is another therapy proposed for reducing bruxism in children. The “self-awareness of movement” concept was put forth to improve the organization and coordination of body movements. However, it was analyzed only by a few studies.[21]
Although local PBM, acupuncture PBM and physiotherapy have been studied in the treatment of bruxism, this is the first study to evaluate the effect of ILIB combined with myofunctional exercises for sleep bruxism in pediatrics.
Author contributions
Conceive and design the study: NOV, SKB, MLLG, RAMF, KPSF, ACRTH; will perform the experiment: NOV, LHB, ANF, MRFS; will analyze the data: EMS, LJM; write the paper: NOV, APTS, MLLG, SKB.
Conceptualization: Natalia Osorio Viarengo, Raquel Agnelli Mesquita-Ferrari, Kristianne Porta Santos Fernandes, Anna Carolina Ratto Tempestini Horliana, Sandra Kalil Bussadori.
Formal analysis: Elaine Marcilio Santos, Lara Jansiski Motta.
Investigation: Natalia Osorio Viarengo, Laura Hermida Bruno, Ana Laura Fossati, María Roxana Ferreira Sertaje.
Methodology: Natalia Osorio Viarengo.
Supervision: Sandra Kalil Bussadori.
Writing – original draft: Natalia Osorio Viarengo.
Writing – review & editing: Marcela Leticia Leal Gonçalves, Ana Paula Taboada Sobral, Sandra Kalil Bussadori.
Abbreviations:
CG =
control group
ILIB =
intravascular irradiation of blood
MFT =
myofunctional therapy
PBM =
photobiomodulation
SPIRIT =
standard protocol items: recommendations for interventional trials
TMD =
temporomandibular disorders
The datasets generated during and/or analyzed during the current study are available from the corresponding author on reasonable request.
The study will be conducted in accordance with the guidelines of good clinical practice and has been approved by the Research Ethics Committee of Universidad Católica del Uruguay (process number 220211). After clarification by the researcher responsible for the procedures, their guardians will sign a Free and Informed Written Consent Form and the participants will sign an Assent Form. The identity of all individuals will be preserved in all stages of the research. Changes in the study will be reported to the same ethics committee. This will guarantee the confidentiality of each patient’s data. The individual who does not attend the scheduled session will be excluded from the study. No harms are expected, and ulterior assistance participants may need, will be provided.
The researcher will be previously trained to collect data and conduct the procedures. All data will be entered electronically. The participants’ files will be stored in numerical order in a safe place and accessible only to the authors of this study.
The application of ILIB and the orofacial myofunctional therapy offer a minimal risk. However, the use of analgesics will be considered according to clinical tolerance. These participants will be excluded from the study and will be followed up. The participants will be told that they may withdraw from the study at any time for any reason, if they so desire. The researchers will also be able to remove the participants from the study, if deemed necessary. Interim results, in case the trial needs to be terminated (corresponding author’s decision), will be accessible only to the authors.
The corresponding author, Sandra Kalil Bussadori, has received a grant from Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq), under the number 306577/2020-8. Kristianne Porta Santos Fernandes has received a grant from Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq), under the number 304330/2020-5. Raquel Agnelli Mesquita-Ferrari has received a grant from Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq), under the number 310491/2021-5.
The authors have no conflicts of interest to disclose.
How to cite this article: Viarengo NO, Gonçalves MLL, Bruno LH, Fossati AL, Sertaje MRF, Santos EM, Sobral APT, Mesquita-Ferrari RA, Fernandes KPS, Horliana ACRT, Motta LLJ, Bussadori SK. Evaluation of intravascular irradiation of blood in children with sleep bruxism: Study protocol for a randomized controlled clinical trial. Medicine 2022;101:44(e31230).
Article information
Medicine (Baltimore). 2022 Nov 4; 101(44): e31230.
Published online 2022 Nov 4. doi: 10.1097/MD.0000000000031230
PMCID: PMC9646657
PMID: 36343030
Natalia Osorio Viarengo, MS,a,b Marcela Leticia Leal Gonçalves, PhD,b,c Laura Hermida Bruno, MS,a,b Ana Laura Fossati, MS,a,b María Roxana Ferreira Sertaje, MS,a,b Elaine Marcilio Santos, PhD,c Ana Paula Taboada Sobral, PhD,b,c Raquel Agnelli Mesquita-Ferrari, PhD,b Kristianne Porta Santos Fernandes, PhD,b Anna Carolina Ratto Tempestini Horliana, PhD,b Lara Jansiski Motta, PhD,b and Sandra Kalil Bussadori, PhDb,*
a Universidad Católica del Uruguay (UCU), Montevideo, Uruguay, South America
b Post Graduation Program in Biophotonics Applied to Health Sciences, Universidade Nove de Julho, São Paulo, SP, Brazil
c Postgraduation Program in Health and Environment, Universidade Metropolitana de Santos, Santos, SP, Brazil.
Corresponding author.
Natalia Osorio Viarengo: moc.liamg@97aivotan; Marcela Leticia Leal Gonçalves: moc.liamtoh@laellalecram; Laura Hermida Bruno: moc.liamg@onurbadimreharual; Ana Laura Fossati: moc.liamg@itassofarualana; María Roxana Ferreira Sertaje: yu.ude.ucu@ARIERREF.ANAXOR; Elaine Marcilio Santos: rb.seminu@oilicram.eniale; Ana Paula Taboada Sobral: rb.moc.adaobat@aluapana; Raquel Agnelli Mesquita-Ferrari: moc.liamg@atiuqsem.leuqar; Kristianne Porta Santos Fernandes: moc.liamg@atropennaitsirk; Anna Carolina Ratto Tempestini Horliana: moc.liamg@htrcanna; Lara Jansiski Motta: rb.moc.arret@attomjaral
*Correspondence: Sandra Kalil Busssadori. Professor of the Postgraduate Program on Biophotonics Applied to Health Sciences, Nove de Julho University, Vergueiro Street, 235/249 Liberdade, ZIP 01504-001, São Paulo SP, Brazil (e-mail: moc.liamg@bks.ardnas).
Received 2022 Aug 10; Received 2022 Sep 6; Accepted 2022 Sep 13.
Copyright © 2022 the Author(s). Published by Wolters Kluwer Health, Inc.
This is an open access article distributed under the Creative Commons Attribution License 4.0 (CCBY), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Articles from Medicine are provided here courtesy of Wolters Kluwer Health
References
[1] Lavigne GJ, Rompré PH, Montplaisir JY. Sleep bruxism: validity of clinical research diagnostic criteria in a controlled polysomnographic study. J Dent Res. 1996;75:546–52. [PubMed] [Google Scholar]
[2] Lobbezoo F, Ahlberg J, Glaros AG, et al.. Bruxism defined and graded: an international consensus. J Oral Rehabil. 2013;40:2–4. [PubMed] [Google Scholar]
[3] Lobbezoo F, Ahlberg J, Raphael KG, et al.. International consensus on the assessment of bruxism: report of a work in progress. J Oral Rehabil. 2018;45:837–44. [PMC free article] [PubMed] [Google Scholar]
[4] Emodi-Perlman A, Eli I, Friedman-Rubin P, et al.. Bruxism, oral parafunctions, anamnestic and clinical findings of temporomandibular disorders in children. J Oral Rehabil. 2012;39:126–35. [PubMed] [Google Scholar]
[5] Guo H, Wang T, Li X, et al.. What sleep behaviors are associated with bruxism in children? A systematic review and meta-analysis. Sleep Breath. 2017;21:1013–23. [PubMed] [Google Scholar]
[6] Nieto Mena S, Tiscareño H, Castellanos JL. Neurofisiología y bruxismo. Revision. Revista ADM. 2018;75:202–13. [Google Scholar]
[7] Barclay N, Gregory A. Quantitative genetic research on sleep: a review of normal sleep, sleep disturbances and associated emotional, behavioural and health-related difficulties. Sleep Med. 2013;17:29–40. [PubMed] [Google Scholar]
[8] Machado E, Dal-Fabbro C, Cunali PA, et al.. Prevalence of sleep bruxism in children: a systematic review. Dental Press J Orthod. 2014;19:54–61. [PMC free article] [PubMed] [Google Scholar]
[9] Al-Khudhairy MW. A systematic review of therapeutic modalities used in sleep bruxism. Saudi J Oral Sci. 2015;2:55–62. [Google Scholar]
[10] Gutiérrez RMF, Miralles LR, Fuentes del CAD, et al.. Bruxismo y su relación con otorrinolaringología: una revisión de la literatura. Revista de Otorrinolaringología y Cirugía de Cabeza y Cuello. 2021;81:153–62. [Google Scholar]
[11] Macedo CR, Macedo EC, Torloni MR, et al.. Pharmacotherapy for sleep bruxism. Cochrane Database Syst Rev. 2014;10:Cd005578. [PubMed] [Google Scholar]
[12] Alcolea JM, Mkhitaryan L. Tratamiento del bruxismo con toxina botulínica tipo A. Estudio clínico prospectivo. Cirugía Plástica Ibero-Latinoamericana. 2019;45:435–48. [Google Scholar]
[13] Dubé C, Rompré PH, Manzini C, et al.. Quantitative polygraphic controlled study on efficacy and safety of oral splint devices in tooth-grinding subjects. J Dent Res. 2004;83:398–403. [PubMed] [Google Scholar]
[14] Hamblin MR. Mechanisms and applications of the anti-inflammatory effects of photobiomodulation. AIMS Biophys. 2017;4:337–61. [PMC free article] [PubMed] [Google Scholar]
[15] Farivar S, Malekshahabi T, Shiari R. Biological effects of low level laser therapy. J Lasers Med Sci. 2014;5:58–62. [PMC free article] [PubMed] [Google Scholar]
[16] Isabella A, Silva J, da Silva T. Effect of irradiation with intravascular laser on the hemodynamic variables of hypertensive patients: study protocol for prospective blinded randomized clinical trial. Medicine. 2019;98:e15111. [PMC free article] [PubMed] [Google Scholar]
[17] KazemiKhoo N, Ansari F. Blue or red: which intravascular laser light has more effects in diabetic patients? Lasers Med Sci. 2015;30:363–6. [PubMed] [Google Scholar]
[18] Kayamori F, Bianchini EMG. Effects of orofacial myofunctional therapy on the symptoms and physiological parameters of sleep breathing disorders in adults: a systematic review. Rev CEFAC. 2017;19:868–78. [Google Scholar]
[19] Aarab G, Arcache P, Lavigne GJ, et al.. The effects of mandibular advancement appliance therapy on jaw-closing muscle activity during sleep in patients with obstructive sleep apnea: a 3-6 months follow-up. J Clin Sleep Med. 2020;16:1545–53. [PMC free article] [PubMed] [Google Scholar]
[20] Salgueiro MCC, Bortoletto CC, Horliana ACRT, et al.. Evaluation of muscle activity, bite force and salivary cortisol in children with bruxism before and after low level laser applied to acupoints: study protocol for a randomized controlled trial. BMC Complement Altern Med. 2017;17:391. [PMC free article] [PubMed] [Google Scholar]
[21] Bulanda S, Ilczuk-Rypuła D, Nitecka-Buchta A, et al.. Sleep bruxism in children: etiology, diagnosis, and treatment—a literature review. Int J Environ Res Public Health. 2021;18:9544. [PMC free article] [PubMed] [Google Scholar]
[22] Salgueiro MDCC, Kobayashi FY, Motta LJ, et al.. Effect of photobiomodulation on salivary cortisol, masticatory muscle strength, and clinical signs in children with sleep bruxism: a randomized controlled trial. Photobiomodul Photomed Laser Surg. 2021;39:23–9. [PubMed] [Google Scholar]
[23] Sobral AP, Sobral SS, Campos TM, et al.. Photobiomodulation and myofascial temporomandibular disorder: systematic review and meta-analysis followed by cost-effectiveness analysis. J Clin Exp Dent. 2021;13:e724–32. [PMC free article] [PubMed] [Google Scholar]
Citation
Comments